BRPI0813689A2 - Profármacos de aminoacila como substância ativa medicamentosa para doenças tramboembólicas - Google Patents

Profármacos de aminoacila como substância ativa medicamentosa para doenças tramboembólicas

Info

Publication number
BRPI0813689A2
BRPI0813689A2 BRPI0813689-0A2A BRPI0813689A BRPI0813689A2 BR PI0813689 A2 BRPI0813689 A2 BR PI0813689A2 BR PI0813689 A BRPI0813689 A BR PI0813689A BR PI0813689 A2 BRPI0813689 A2 BR PI0813689A2
Authority
BR
Brazil
Prior art keywords
tramboembolic
prophrames
medictive
aminoacyl
diseases
Prior art date
Application number
BRPI0813689-0A2A
Other languages
English (en)
Inventor
Hans-Georg Lerchen
Ursula Krenz
Michael Haerter
Mark Jean Gnoth
Georges Von Degenfeld
Elke Dittrich-Wengenroth
Anja Bucmueller
Susanne Roehrig
Swen Allerheiligen
Elisabeth Perzborn
Christoph Gerdes
Karl-Heinz Schlemmer
Metin Akbaba
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of BRPI0813689A2 publication Critical patent/BRPI0813689A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BRPI0813689-0A2A 2007-07-11 2008-06-28 Profármacos de aminoacila como substância ativa medicamentosa para doenças tramboembólicas BRPI0813689A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007032347A DE102007032347A1 (de) 2007-07-11 2007-07-11 Aminoacyl-Prodrugs
PCT/EP2008/005301 WO2009007026A1 (de) 2007-07-11 2008-06-28 Aminoacyl-prodrugs als arzneimittelwirkstoff für thromboembolische erkrankungen

Publications (1)

Publication Number Publication Date
BRPI0813689A2 true BRPI0813689A2 (pt) 2014-12-30

Family

ID=39790003

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0813689-0A2A BRPI0813689A2 (pt) 2007-07-11 2008-06-28 Profármacos de aminoacila como substância ativa medicamentosa para doenças tramboembólicas

Country Status (12)

Country Link
US (1) US20100273789A1 (pt)
EP (1) EP2209776A1 (pt)
JP (1) JP2010532770A (pt)
KR (1) KR20100031534A (pt)
CN (1) CN101790528A (pt)
AU (1) AU2008274577A1 (pt)
BR (1) BRPI0813689A2 (pt)
CA (1) CA2693603A1 (pt)
DE (1) DE102007032347A1 (pt)
IL (1) IL202361A0 (pt)
RU (1) RU2010104473A (pt)
WO (1) WO2009007026A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007028320A1 (de) * 2007-06-20 2008-12-24 Bayer Healthcare Ag Substituierte Oxazolidinone und ihre Verwendung
EP2838897A1 (en) 2012-04-16 2015-02-25 Ranbaxy Laboratories Limited Process for the preparation of rivaroxaban and intermediates thereof
WO2013175431A1 (en) 2012-05-24 2013-11-28 Ranbaxy Laboratories Limited Process for the preparation of rivaroxaban
CN103833724A (zh) * 2012-11-20 2014-06-04 上海医药工业研究院 一种5-氯噻吩-2-甲酰氯的制备方法
WO2015011617A1 (en) * 2013-07-23 2015-01-29 Ranbaxy Laboratories Limited Process for the preparation of rivaroxaban

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE248835T1 (de) 1999-06-25 2003-09-15 Vertex Pharma Prodrugs von impdh-inhibierenden carbamaten
US7049443B2 (en) 2001-07-12 2006-05-23 Pharmacia & Upjohn Company Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound
DE10300111A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
US7135575B2 (en) * 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
US7265140B2 (en) 2003-09-23 2007-09-04 Pfizer Inc Acyloxymethylcarbamate prodrugs of oxazolidinones
DE102006007146A1 (de) * 2006-02-16 2007-08-23 Bayer Healthcare Ag Aminoacyl-Prodrugs

Also Published As

Publication number Publication date
AU2008274577A1 (en) 2009-01-15
US20100273789A1 (en) 2010-10-28
WO2009007026A1 (de) 2009-01-15
RU2010104473A (ru) 2011-08-20
EP2209776A1 (de) 2010-07-28
CN101790528A (zh) 2010-07-28
JP2010532770A (ja) 2010-10-14
IL202361A0 (en) 2010-06-30
KR20100031534A (ko) 2010-03-22
CA2693603A1 (en) 2009-01-15
DE102007032347A1 (de) 2009-01-15

Similar Documents

Publication Publication Date Title
BRPI1012247A2 (pt) compostos inseticidas
BRPI1015931A2 (pt) Compostos inseticidas
BRPI1007310A2 (pt) Compostos inseticidas.
BRPI0917549A2 (pt) dispositivo para a liberação de um medicamento
BRPI0917203A2 (pt) Derivado de benzenodicarboxamida inseticida
BRPI0917369A2 (pt) Compostos inseticidas
BRPI0918500A2 (pt) compostos inseticidas
BRPI0917188A2 (pt) Compostos inseticidas
BRPI0922845A2 (pt) pirazol-4-n-alcoxicarboxamidas como microbiocidas
BRPI0910282A2 (pt) Composto oxadiazo-antraceno para o tratamento de diabetes
BRPI0917675A2 (pt) compostos orgânicos para cura de ferida
BRPI0908874A2 (pt) mecanismo de posicionamento de um leito
BRPI0919295A2 (pt) 1h-benzimidazol-5-carboxamidas como agentes anti-inflamatórios.
BRPI0821831A2 (pt) Compostos inseticidas
BR112012003870A2 (pt) derivados de sulfeto substituídos com 3-triazolilfenila como acaricidas e inseticidas
BRPI0918430A2 (pt) 4-fenil-1h-pirazóis inseticidas.
BRPI0918064A2 (pt) distribuidor de substância
BRPI0915093A2 (pt) conjugados para a administração de compostos biologicamente ativos
BRPI0815670A2 (pt) Inseticidas
EP1976651A4 (en) ACTIVE, RECONFIGURABLE STRUCTURE FORMING
BRPI1016190A2 (pt) compostos farmacêuticos.
BRPI1014077A2 (pt) Derivados de tiazolilperidina como fungicidas
BRPI1008664A2 (pt) comprimidos para a terapia de combinação
BRPI1013941A2 (pt) compostos inseticidas
EP2569042A4 (en) CATHETER SHAPE ADJUSTMENT MECHANISM

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]